David E Moller

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Top Venues

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Sophie Hallakou-Bozec, Micheline Kergoat, Pascale Fouqueray, Sébastien Bolze, David E Moller
Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action. PloS one 16 (2) (2021)
Sophie Hallakou-Bozec, Guillaume Vial, Micheline Kergoat, Pascale Fouqueray, Sébastien Bolze, Anne Laure Borel, Eric Fontaine, David E Moller
Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes. Diabetes, obesity & metabolism 23 (3) (2020)
Sophie Hallakou-Bozec, Micheline Kergoat, David E Moller, Sébastien Bolze
Imeglimin preserves islet β-cell mass in Type 2 diabetic ZDF rats. Endocrinology, diabetes & metabolism 4 (2) (2020)